ArticleJournal for immunotherapy of cancer2020

FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion.

Robert J Oldham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.